The Fast Track to IND: Accelerated CLD Development through the Early Identification of High Producers

Previously Aired on September 27, 2023

Sign Up:

First Name *

* Required

Last Name *

* Required

Company *

* Required

City *

* Required

Post Code or Zip *

* Required

Country *

* Required

Email *

* Required

Phone *

* Required

Which one of these best describes you? *

Do not contact me at this time, just learning.Interested, please contact me about my needs. * Required

I would like to receive more information about Sartorius’ products and services via e-mail. I can revoke my consent at any time with effect for the future by sending an email to unsubscribe@sartorius.com or by clicking the unsubscribe link in e-mails I receive.

YesNo * Required

Would you like to receive more content from American Pharmaceutical Review? Please select below:

Email updates, product alerts, and special offers e-Newsletters Digital Edition of American Pharmaceutical Review (FREE of charge) * Required

The webinar sponsor, Sartorius and CompareNetworks may use the information you have provided to contact you about this webinar and other related topics. For more information please refer to our privacy policy.

* Required

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Overview

Learn about Sartorius’ innovative automated cell line development (CLD) service and media with a successful track record on many CHO-based protein expression systems for – IgG1, IgG2, IgG4, Fc-Fusion, Bi-Specifics, and more.

In this webinar, you will learn how to:

Produce stable, ready-to-use clones in 9 weeks through automation, high-throughput isolation, and single-cell cloning technology
Achieve predictable protein titers: up to 10 g/L
The assurance of product quality through protein characterization
Compliance with GMP standards through our cell banking service
Ensure biosafety through validated GMP release testing, sterility testing for mycoplasma and viruses, and genetic characterization

Who should attend:

Head/Director of Cell Line Development
Head/Director of Process Development
CSO; CDO; Sr Scientist
MSAT Manager
Project Manager
Vice President R&D

Presenters

Dr. Yash D. Patel

Product Specialist Cell Line Development
Sartorius
View Biography

Mike Auerbach

(Moderator)
Editor-in-Chief,
American Pharmaceutical Review